Empty Capsules Market size is slated to increase exponentially from 2022 to 2028, on account of the cost-effectiveness of homemade vitamin and herbal supplements over purchasing pre-packaged supplements. In addition, the rising awareness about the benefits of capsules over tablets, including higher drug absorption, tamper-resistance, and tastelessness, will also augment the consumption of empty pill capsules in the upcoming years. Empty capsules refer to tubes commonly used to store powders, herbs, and medicines. They are made available in a variety of sizes in both vegetable and gelatin capsules. The product features a positive mechanical lock, eliminating problems like dented ends and separation after filling.
Rise of the elderly population base and the significant expansion of the pharmaceutical sector in developing economies are the prominent trends driving the empty capsules market outlook through 2028. Since the geriatric population is vulnerable to diseases and serious complications, the adoption of pharmaceutical products will increase considerably and in turn, influence the business of empty capsules suppliers worldwide. Furthermore, the global burden of chronic and infectious diseases, coupled with the escalating generic drug production, will also add impetus to industry expansion during the forecast timeframe.
On the basis of application, the global empty capsules market from the anti-inflammatory segment will depict a high growth rate through 2028. This can be credited to the favorable business landscape for the drug-makers of rheumatoid arthritis disease due to its gradually increasing prevalence. As per the Pharma Letter’s report, the cases of rheumatoid arthritis are growing by 1% per year, which will fuel the segment growth, as this disease is associated with the inflammation of joints and organs. The strong focus on addressing the treatment needs of people with autoimmune diseases will further boost the demand for empty capsules for medicines globally.
The Latin America empty capsules market is likely to amass considerable gains by 2028. This is given the high emphasis on the production of generic drugs and the burgeoning pharmaceutical sector in countries such as Brazil. As per ALANUR’s data, the consumption of nutritional supplements including vitamins in the country surged to 59% of consumers. This factor, alongside the significant launch of capsule manufacturing plants, will also generate growth opportunities for the regional industry during the forecast timeline.
Major companies operating in the industry include Sunil Healthcare Ltd., Snail Pharma Industry Co. Ltd., Roxlor LLC, Patheon, Inc. (Thermo Fisher Scientific, JLL/Delta Patheon Holdings, Thermo Fisher Scientific (Panama) B.V.), Shanxi JC Biological Technology Co., Qualicaps, Inc. (Mitsubishi Chemical Holdings), Medicaps Ltd., CapsCanada Corporation, Capsugel, Inc. (Lonza Group AG), Bright Pharma Caps Inc., and ACG Associated Capsules Pvt. Ltd., among others. These companies are focusing on new product launches, collaborations, and partnerships to amplify their business footprint across the competitive market.
For instance, in November 2021, ACG launched a new global nutraceutical campaign ‘ACG loves NOTHING’, which was geared towards producing high-quality empty capsules and improving the overall nutraceutical production. In May 2021, Qualicaps Europe broadened its product portfolio with the launch of a reliable range of capsules, designed in response to the escalating demand for titanium dioxide-free capsules.
The novel coronavirus pandemic has posed massive challenges to industry verticals, including the domestic pharma manufacturing sector. However, although the disease outbreak has disrupted the import of active pharmaceutical ingredients, such as drugs to treat chronic conditions like diabetes to some extent, it has also presented new opportunities for the pharmaceutical industry, in turn fostering demand for empty capsules. Also, the industry is poised to gain traction over the coming years, owing to the higher intake of dietary supplements to boost immune health during the health crisis.
Market, by product
Market, by application
Market, by end-use
The above information is provided for the following regions and countries: